ArticlePloS one2021

A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients.

Joanna Kur-Zalewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.